Positive and negative regulation of granulopoiesis by endogenous RARα

Blood

Volumn 97, Issue 5, 2001, Pages 1314-1320

  Kastner, Philippe ^a,b   Lawrence, H Jeffrey ^a   Waltzinger, Caroline ^a   Ghyselinck, Norbert B ^a   Chambon, Pierre ^a   Chan, Susan ^a,b  

^a INSTITUT DE GÉNÉTIQUE ET DE BIOLOGIE MOLÉCULAIRE ET CELLULAIRE   (France)

^b l'alimentation et l'Environnement   (France)

Author keywords

[No Author keywords available]

Indexed keywords

RETINOIC ACID RECEPTOR;

ANIMAL CELL; ARTICLE; CELL ACTIVITY; CELL CULTURE; CELL DIFFERENTIATION; GENE OVEREXPRESSION; GENE TRANSLOCATION; GRANULOCYTE; GRANULOPOIESIS; MOUSE; NONHUMAN; PRIORITY JOURNAL;

EID: 0035283124     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.V97.5.1314     Document Type: Article

References (59)

1. Deconstructing a disease: RARalpha, its fusion partners, and their roles in the pathogenesis of acute promyelocytic leukemia
2. Molecular genetics of acute promyelocytic leukemia
3. Acute promyelocytic leukemia: From treatment to genetics and back
4. The transcriptional role of PML and the nuclear body
5. Fusion between a novel Kruppel-like zinc finger gene and the retinoic acid receptor-alpha locus due to a variant t(11;17) translocation associated with acute promyelocytic leukaemia
6. Fusion of retinoic acid receptor alpha to NuMA, the nuclear mitotic apparatus protein, by a variant translocation in acute promyelocytic leukaemia
7. The t(5;17) variant of acute promyelocytic leukemia expresses a nucleophosmin-retinoic acid receptor fusion
8. The signal transducer and activator of transcription STAT5b gene is a new partner of retinoic acid receptor alpha in acute promyelocytic-like leukaemia
9. Distinct interactions of PML-RARalpha and PLZF-RARalpha with co-repressors determine differential responses to RA in APL
10. Distinct leukemia phenotypes in transgenic mice and different corepressor interactions generated by promyelocytic leukemia variant fusion genes PLZF-RARalpha and NPM-RARalpha
11. Leukemia initiated by PMLRARalpha: The PML domain plays a critical role while retinoic acid-mediated transactivation is dispensable
12. SMRT corepressor interacts with PLZF and with the PML-retinoic acid receptor alpha (RARalpha) and PLZF-RARalpha oncoproteins associated with acute promyelocytic leukemia
13. Role of the histone deacetylase complex in acute promyelocytic leukaemia
14. Fusion proteins of the retinoic acid receptor-alpha recruit histone deacetylase in promyelocytic leukaemia
15. Reduced retinoic acid-sensitivities of nuclear receptor corepressor binding to PML- and PLZF-RARalpha underlie molecular pathogenesis and treatment of acute promyelocytic leukemia
16. Differential expression of retinoid receptors during multilineage differentiation of haematopoietic progenitor cells: Role of the RARα2 isoform in normal granulopoiesis and leukemia
17. Impaired granulocytic differentiation in vitro in hematopoietic cells lacking retinoic acid receptors alpha1 and gamma
18. Expression of retinoic acid receptor alpha mRNA in human leukemia cells
19. Induction of differentiation of the human promyelocytic leukemia cell line (HL-60) by retinoic acid
20. Retinoid acid supports granulocytic but not erythroid differentiation of myeloid progenitors in normal bone marrow cells
21. A dominant negative retinoic acid receptor blocks neutrophil differentiation at the promyelocyte stage
22. Overexpression of retinoic acid receptor alpha suppresses myeloid cell differentiation at the promyelocyte stage
23. Overexpression of wild-type retinoic acid receptor alpha (RARalpha) recapitulates retinoic acid-sensitive transformation of primary myeloid progenitors by acute promyelocytic leukemia RARalpha-fusion genes
24. Dual action of retinoic acid on human embryonic/fetal hematopoiesis: Blockade of primitive progenitor proliferation and shift from multipotent/erythroid/monocytic to granulocytic differentiation program
25. High postnatal lethality and testis degeneration in retinoic acid receptor alpha mutant mice
26. Function of retinoic acid receptor gamma in the mouse
27. Cellular retinol-binding protein 1 is essential for vitamin A homeostasis
28. Function of the retinoic acid receptors (RARs) during development (1): Craniofacial and skeletal abnormalities in RAR double mutants
29. All-trans- and 9-cis-retinoic acid: Potent direct inhibitors of primitive murine hematopoietic progenitors in vitro
30. Characterization and regulation of RB6-8C5 antigen expression on murine bone marrow cells
31. The effect of vitamin A deficiency on the in vitro cellular immune response of rats
32. Nuclear receptor repression mediated by a complex containing SMRT, mSin3A, and histone deacetylase
33. A transcriptional co-repressor that interacts with nuclear hormone receptors
34. Ligand-independent repression by the thyroid hormone receptor mediated by a nuclear receptor co-repressor
35. Neutrophil maturation and the role of retinoic acid
36. Vitamin A deficiency in mice causes a systemic expansion of myeloid cells
37. Multiple isoforms of the mouse retinoic acid receptor alpha are generated by alternative splicing and differential induction by retinoic acid
38. Modulation of mRNA expression of a novel human myeloid-selective CCAAT/enhancer binding protein gene (C/EBP epsilon)
39. CCAAT/enhancer binding protein epsilon is a potential retinoid target gene in acute promyelocytic leukemia treatment
40. Impaired granulopoiesis, myelodysplasia, and early lethality in CCAAT/enhancer binding protein epsilon-deficient mice
41. Transcriptional activation of the Cdk inhibitor p21 by vitamin D3 leads to the induced differentiation of the myelomonocytic cell line U937
42. Cip/Kip cyclin-dependent kinase inhibitors: Brakes of the cell cycle engine during development
43. Expression of p21(Cip1/Waf1/Sdi1) and p27 (Kip1) cyclin-dependent kinase inhibitors during human hematopoiesis
44. 1,25-Dihydroxyvitamin D3 induces differentiation of a retinoic acid-resistant acute promyelocytic leukemia cell line (UF-1) associated with expression of p21 (WAF1/CIP1) and p27(KIP1)
45. Subcellular and cell-cycle expression profiles of CDK-inhibitors in normal differentiating myeloid cells
46. Transcriptional activation of the human p21(WAF1/CIP1) gene by retinoic acid receptor: Correlation with retinoid induction of U937 cell differentiation
47. The role of HOX homeobox genes in normal and leukemic hematopoiesis
48. Targeted disruption of the MYC antagonist MAD1 inhibits cell cycle exit during granulocyte differentiation
49. Changing the differentiation program of hematopoietic cells: Retinoic acid-induced shift of eosinophil-committed cells to neutrophils
50. All-trans retinoic acid enhances the long-term repopulating activity of cultured hematopoietic stem cells
51. The acute promyelocytic leukemia-specific PML-RAR alpha fusion protein inhibits differentiation and promotes survival of myeloid precursor cells
52. The PML-RAR alpha gene product of the t(15;17) translocation inhibits retinoic acid-induced granulocytic differentiation and mediated transactivation in human myeloid cells
53. Structure, localization and transcriptional properties of two classes of retinoic acid receptor alpha fusion proteins in acute promyelocytic leukemia (APL): Structural similarities with a new family of oncoproteins
54. Genomic variability and alternative splicing generate multiple PML/RAR alpha transcripts that encode aberrant PML proteins and PML/RAR alpha isoforms in acute promyelocytic leukaemia
55. The thyroid hormone receptor functions as a ligand-operated developmental switch between proliferation and differentiation of erythroid progenitors
56. PML is essential for multiple apoptotic pathways
57. PML induces a novel caspase-independent death process
58. PML regulates p53 acetylation and premature senescence induced by oncogenic Ras
59. Oligomerization of RAR and AML1 transcription factors as a novel mechanism of oncogenic activation